(Q39460266)

English

Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.

scientific article published on 10 October 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Bruno S Pessôa

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Elisa B M I Peixoto

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Alexandros Papadimitriou

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jacqueline M Lopes de Faria

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

José B Lopes de Faria

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

10 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Journal of the Renin-Angiotensin-Aldosterone System

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

56-66

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mechanisms of diabetic nephropathy: role of hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

The pathobiology of diabetic complications: a unifying mechanism

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Molecular mechanisms of diabetic renal hypertrophy

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

NAD(P)H oxidase: role in cardiovascular biology and disease

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.

1 reference

https://api.crossref.org/works/10.1177%2F1470320311422581

21 January 2018

Identifiers

10.1177/1470320311422581

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39460266&oldid=1584138607"